Showing results (51-60 of 1,275) with videos related to

Sort By:
Pageof 128
The Clinical Investigator|January 1, 1992
Clinical pharmacology of carvedilolB Tomlinson, B N Prichard, B R Graham, et al.
Clinical Science (London, England : 1979)|May 1, 1986
Stimulus-induced release of endogenous catecholamines from human washed plateletsC C Smith, A P Wilson, B N Prichard, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertensionB N Prichard, F O Thompson, A J Boakes, et al.
Clinical Science (London, England : 1979)|July 1, 1987
Platelet catecholamines and platelet function in normal human subjectsA P Wilson, C C Smith, B N Prichard, et al.
British Journal of Clinical Pharmacology|April 1, 1995
The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjectsN A Alarayyed, B R Graham, B N Prichard, et al.
European Journal of Clinical Investigation|June 1, 1989
Platelet noradrenaline release in patients with familial hypercholesterolaemiaC C Smith, A P Wilson, B N Prichard, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Bromocriptine in the treatment of hypertensionR J Walden, J Hernandez, P Bhattacharjee, et al.
Platelets|January 1, 1997
Influence of the alpha-adrenoreceptor naftopidil and doxazosin, on adrenaline-induced serotonin platelets: comparison with the antagonists, collagen and efflux by human effects of nifedipineN A Alarayyed, B N Prichard, D J Betteridge, et al.
Postgraduate Medical Journal|January 1, 1981
Obstructive sodium-losing nephropathy--a case report and reviewP P Nunn, C W Owens, C B Scholberg, et al.
Acta Cardiologica|January 1, 1991
Heart and catecholaminesB N Prichard, C W Owens, C C Smith, et al.
Pageof 128